Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
02/07/202112h15UK RegulatoryHutchmed (China) Limited Holding(s) in CompanyLSE:0J7GHutchison China Meditech Ltd
02/07/202110h30UK RegulatoryHutchmed (China) Limited Notice of ResultsLSE:0J7GHutchison China Meditech Ltd
01/07/202112h00RNS Non-RegulatoryHutchmed (China) Limited US FDA Accepts NDA Filing for SurufatinibLSE:0J7GHutchison China Meditech Ltd
30/06/202111h02UK RegulatoryHutchmed (China) Limited Holdings in CompanyLSE:0J7GHutchison China Meditech Ltd
30/06/202111h01UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
30/06/202111h00UK RegulatoryHutchmed (China) Limited Closing of Global Offering and Hong Kong ListingLSE:0J7GHutchison China Meditech Ltd
29/06/202108h00UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
23/06/202116h21UK RegulatoryHutchmed (China) Limited HUTCHMED Announces Pricing of Global OfferingLSE:0J7GHutchison China Meditech Ltd
22/06/202119h22UK RegulatoryHutchmed (China) Limited Savolitinib approved in China for lung cancerLSE:0J7GHutchison China Meditech Ltd
18/06/202117h05UK RegulatoryHutchmed (China) Limited HUTCHMED Announces NMPA Approval of SurufatinibLSE:0J7GHutchison China Meditech Ltd
18/06/202108h01UK RegulatoryHutchmed (China) Limited HUTCHMED Launches Hong Kong IPOLSE:0J7GHutchison China Meditech Ltd
18/06/202108h00UK RegulatoryHutchmed (China) Limited Disclosure UpdateLSE:0J7GHutchison China Meditech Ltd
20/05/202108h00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ASCO21LSE:0J7GHutchison China Meditech Ltd
17/05/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Host Company UpdateLSE:0J7GHutchison China Meditech Ltd
07/05/202113h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Attend Upcoming Investor ConferencesLSE:0J7GHutchison China Meditech Ltd
04/05/202109h00UK RegulatoryHutchison China Meditech Limited Change of Company NameLSE:0J7GHutchison China Meditech Ltd
04/05/202108h00RNS Non-RegulatoryHutchison China Meditech Limited Surufatinib FDA Rolling NDA Submission CompletedLSE:0J7GHutchison China Meditech Ltd
30/04/202117h41UK RegulatoryHutchison China Meditech Limited Second Price Monitoring ExtnLSE:0J7GHutchison China Meditech Ltd
30/04/202117h35UK RegulatoryHutchison China Meditech Limited Price Monitoring ExtensionLSE:0J7GHutchison China Meditech Ltd
29/04/202108h00RNS Non-RegulatoryHutchison China Meditech Limited Phase II Registration Study of HMPL-689 InitiatedLSE:0J7GHutchison China Meditech Ltd
28/04/202115h20UK RegulatoryHutchison China Meditech Limited Result of AGMLSE:0J7GHutchison China Meditech Ltd
23/04/202108h00UK RegulatoryHutchison China Meditech Limited Vesting of awards under Long Term Incentive PlanLSE:0J7GHutchison China Meditech Ltd
14/04/202111h30UK RegulatoryHutchison China Meditech Limited Notification of Dilution of Voting RightsLSE:0J7GHutchison China Meditech Ltd
08/04/202109h30UK RegulatoryHutchison China Meditech Limited $100m Investment by Baring Private Equity AsiaLSE:0J7GHutchison China Meditech Ltd
31/03/202108h00UK RegulatoryHutchison China Meditech Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
29/03/202110h30UK RegulatoryHutchison China Meditech Limited Grant of LTIP Awards and Share OptionsLSE:0J7GHutchison China Meditech Ltd
29/03/202108h00RNS Non-RegulatoryHutchison China Meditech Limited Initiates International Phase I Trials of HMPL-306LSE:0J7GHutchison China Meditech Ltd
26/03/202108h00UK RegulatoryHutchison China Meditech Limited Annual Financial ReportLSE:0J7GHutchison China Meditech Ltd
24/03/202114h30UK RegulatoryHutchison China Meditech Limited Agreement to Divest Non-Core OTC Joint VentureLSE:0J7GHutchison China Meditech Ltd
24/03/202108h00RNS Non-RegulatoryHutchison China Meditech Limited Phase Ib/II Trial of Surufatinib with TislelizumabLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G